当前位置：药药网 / 药品 / 美国FDA药品数据库(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分：持证企业：
 美国药品NDC（国家药品编码）与药品说明书数据库31条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Levetiracetam in Sodium Chloride
Levetiracetam in Sodium Chloride
0143-9281
Hikma Pharmaceuticals USA Inc.
20250208
LEVETIRACETAM
ANDA
5
anda211356
Levetiracetam in Sodium Chloride
Levetiracetam in Sodium Chloride
0143-9282
Hikma Pharmaceuticals USA Inc.
20250208
LEVETIRACETAM
ANDA
10
anda211356
Levetiracetam in Sodium Chloride
Levetiracetam in Sodium Chloride
0143-9283
Hikma Pharmaceuticals USA Inc.
20250208
LEVETIRACETAM
ANDA
15
anda211356
iron sucrose
Venofer
0517-2310
American Regent, Inc.
20070612
IRON SUCROSE
NDA
20
nda021135
iron sucrose
Venofer
0517-2325
American Regent, Inc.
20110127
IRON SUCROSE
NDA
20
nda021135
iron sucrose
Venofer
0517-2340
American Regent, Inc.
20140714
IRON SUCROSE
NDA
20
nda021135
iron sucrose
Venofer
0517-2340
American Regent, Inc.
20001110
IRON SUCROSE
NDA
20
nda021135
Norepinephrine Bitartrate
NOREPINEPHRINE BITARTRATE
0781-3755
Sandoz Inc
20190423
NOREPINEPHRINE BITARTRATE
ANDA
1
anda211359
iron sucrose
Venofer
49230-530
Fresenius Medical Care Holdings, Inc.
20110127
IRON SUCROSE
NDA
20
nda021135
iron sucrose
Venofer
49230-534
Fresenius Medical Care Holdings, Inc.
20081104
IRON SUCROSE
NDA
20
nda021135
lumacaftor and ivacaftor
ORKAMBI
51167-122
Vertex Pharmaceuticals Incorporated
20220902
IVACAFTOR; LUMACAFTOR
NDA
94; 75
nda211358
lumacaftor and ivacaftor
ORKAMBI
51167-500
Vertex Pharmaceuticals Incorporated
20180807
IVACAFTOR; LUMACAFTOR
NDA
188; 150
nda211358
lumacaftor and ivacaftor
ORKAMBI
51167-900
Vertex Pharmaceuticals Incorporated
20180807
IVACAFTOR; LUMACAFTOR
NDA
125; 100
nda211358
VENOFER (IRON SUCROSE)
VENOFER (IRON SUCROSE)
51662-1568
HF Acquisition Co LLC, DBA HealthFirst
20210625
IRON SUCROSE
NDA
20
nda021135
omega-3-acid ethyl esters
omega-3-acid ethyl esters
62135-780
Chartwell RX, LLC
20200219
OMEGA-3-ACID ETHYL ESTERS
ANDA
900
anda211355
Amantadine Hydrochloride
Amantadine Hydrochloride
64380-862
Strides Pharma Science Limited
20221201
AMANTADINE HYDROCHLORIDE
ANDA
100
anda211354
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Dextroamphetamine Saccharate, Amphetamine Aspartat
64850-500
Elite Laboratories, Inc.
20221229
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
ANDA
1.25; 1.25; 1.25; 1.25
anda211352
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Dextroamphetamine Saccharate, Amphetamine Aspartat
64850-501
Elite Laboratories, Inc.
20221229
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
ANDA
1.875; 1.875; 1.875; 1.875
anda211352
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Dextroamphetamine Saccharate, Amphetamine Aspartat
64850-502
Elite Laboratories, Inc.
20221229
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
ANDA
2.5; 2.5; 2.5; 2.5
anda211352
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Dextroamphetamine Saccharate, Amphetamine Aspartat
64850-503
Elite Laboratories, Inc.
20221229
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
ANDA
3.125; 3.125; 3.125; 3.125
anda211352
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3